Alison Moore, Chief Technical Officer at Allogene Therapeutics, Inc. (ALLO), sold 12,328 shares at $38.14 ($470K) on 2021-03-15, disclosed to the SEC on 2021-03-17.
Open-market sale of $470k ALLO by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.14 | 6,164 | $235K | 50.0% |
| 2 | $38.14 | 6,164 | $235K | 50.0% |
| Total | $38.14 avg | 12,328 | $470K | 100% |
| Filing → |
| CDXS | SELL | 2025-10-15 | $16K | — | Filing → |
| ALLO | SELL | 2022-03-17 | $133K | — | Filing → |
| ALLO | SELL | 2020-10-13 | $1.5M | — | Filing → |